Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Preventing and treating amyloid-beta deposition by stimulation of innate immunity

Preventing and treating amyloid-beta deposition by stimulation of innate immunity

US Patent 10960019 · Granted Mar 30, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Immunotherapeutic modulation of amyloidogenic disease using non-fibrillogenic, n2022
Specific murine and humanized monoclonal antibodies detecting pathology associat2020
Monoclonal antibody to treat alzheimer's disease, prion disease, frontotemporal 2020
Preventing and treating amyloid-beta deposition by stimulation of innate immunit2019
Preventing and treating amyloid-beta deposition by stimulation of innate immunit2019
Preventing and treating amyloid-beta deposition by stimulation of innate immunit2019
Preventing and treating amyloid-beta deposition by stimulation of innate immunit2019
Immunotherapy targeting of the shared abnormal conformational state of amyloidog2019
Immunotherapeutic modulation of amyloidogenic disease using non-fibrillogenic, n2018
Immunotherapy targeting of the shared abnormal conformational state of amyloidog2017
Method for treating amyloid disease2017
Mucosal immunization to prevent prion infection2017